MedPath

LSFG-SKIN, Laser Speckle Flowgraphy

Not Applicable
Terminated
Conditions
Radiation Injuries
Vascular Ischemia
Burns
Multiple Sclerosis
Chemotherapy Effect
Uveitis
Scleritis
Stroke
Intracranial Hemorrhages
TIA
Interventions
Device: laser speckle flowgraphy
Registration Number
NCT03660618
Lead Sponsor
Randy Kardon
Brief Summary

The purpose of this project is to quantify normal and abnormal skin blood flow regionally in different areas of the body(face, extremities, over burns and wounds) at baseline and over time in response to treatment or environmental changes, such as temperature, light and pressure.

Detailed Description

Laser speckle skin blood flow (LSFG-SKIN) will be recorded in normal subjects and in patients with disorders affecting skin capillary perfusion, which may include cardiovascular disorders, dermatologic disorders, skin wounds, ocular disorders, psychiatric disorders, and neurologic disorders.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
1
Inclusion Criteria

Controls

●Healthy normal control subjects ages 18-90

Cardiology Subjects

  • Ages 18-90
  • History of dysrhythmia, heart failure, cardiac ischemia, hypertension, peripheral vascular disease

Dermatology Subjects

  • Ages 18-90
  • History of inflammatory and cancerous lesions

Endocrine Subjects

  • Ages 18-90
  • History of diabetes, thyroid disease

Neurology Subjects

  • Ages 18-90
  • History of dementia, headaches, Parkinson's, light sensitivity, stroke, TIA, multiple sclerosis

Psychiatry Subjects

  • Ages 18-90
  • History of bipolar, schizophrenia, anxiety, depression

Surgery Subjects

  • Ages 18-90
  • History of skin wounds(trauma, chemotherapy, radiation), thermal burns, or plastic and reconstructive surgical procedures.

Ophthalmology Subjects

  • Ages 18-90
  • History of ocular disorders caused by hypo perfusion or inflammatory disorders
Exclusion Criteria

Controls

  • Cataract or media opacity that would degrade the imaging of the retina. Mild cataracts are okay.
  • Angle closure glaucoma

Cardiology Subjects

  • Cataract or media opacity that would degrade the imaging of the retina. Mild cataracts are okay.

  • Angle closure glaucoma

    1. Dermatology Subjects
  • Cataract or media opacity that would degrade the imaging of the retina. Mild cataracts are okay.

  • Angle closure glaucoma

Endocrine Subjects

  • Cataract or media opacity that would degrade the imaging of the retina. Mild cataracts are okay.
  • Angle closure glaucoma

Neurology Subjects

  • Cataract or media opacity that would degrade the imaging of the retina. Mild cataracts are okay.
  • Angle closure glaucoma

Psychiatry Subjects

  • Cataract or media opacity that would degrade the imaging of the retina. Mild cataracts are okay.
  • Angle closure glaucoma

Surgery Subjects

  • Cataract or media opacity that would degrade the imaging of the retina. Mild cataracts are okay.
  • Angle closure glaucoma

Ophthalmology Subjects

  • Cataract or media opacity that would degrade the imaging of the retina. Mild cataracts are okay.
  • Angle closure glaucoma

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Clinic Subjectslaser speckle flowgraphycardiology subjects, dermatology subjects, endocrine subjects, neurology subjects, psychiatry subjects, surgery subjects, ophthalmology subjects.
Primary Outcome Measures
NameTimeMethod
Imaging Blood FlowOne visit

Imaging blood flow in the tissue is of major importance in the clinical environment

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Iowa Department of Ophthalmology

🇺🇸

Iowa City, Iowa, United States

© Copyright 2025. All Rights Reserved by MedPath